SBI Life Insurance Reports Strong Q1 Earnings, Yet Shares Dip on Narrowing Margins
SBI Life Insurance opened fiscal 2027 with a mixed quarterly performance. The insurer posted a consolidated net profit of ₹720 crore for the first quarter, a 22% increase year-over-year. Net premium income rose 16.9% to ₹20,078 crore, driven by robust renewal collections and a 40% surge in first-year premiums. Despite these strong fundamentals, the stock slipped in trade as investors focused on a narrowing value of new business (VNB) margin.
Shares of SBI Life were trading at ₹1,861.60 on the NSE, down from the previous close of ₹1,858.60, after touching an intraday low of ₹1,836.20. The market reaction highlights that profitability alone is not enough without margin stability in the insurance sector.
Margin Compression Takes Center Stage
The VNB margin moderated to 26.2% from 27.4% in the same quarter last year. Analysts attribute this decline to a higher share of group protection business, which typically carries thinner margins than individual policies. Management has retained its full-year guidance of 26–28% and expects gradual normalization as individual business regains share through the remaining quarters.
Financial Performance Highlights
- Consolidated net profit: ₹720 crore, up 22% YoY
- Net premium income: ₹20,078 crore, up 16.9% YoY
- Gross written premium: ₹21,290 crore, up 20% YoY
- First year premium: ₹4,955 crore, up 40% YoY
- Annualized premium equivalent (APE): ₹5,380 crore, up 36% YoY
- Embedded value: ₹85,290 crore, up 15% YoY
- Assets under management: ₹5.25 lakh crore, up 10% YoY
- Solvency ratio: 1.96, well above regulatory norms
Brokerages Remain Bullish Despite Margin Dip
Motilal Oswal retained its Buy rating with a revised target price of ₹2,240, trimming its FY27 margin estimate slightly but maintaining overall earnings estimates. Prabhudas Lilladher also holds a Buy stance with a target of ₹2,200. Both brokerages expect steady APE growth and margin recovery as the business mix normalizes.
Management reiterated its medium-term outlook, expecting 14–15% individual premium growth in FY27, supported by continued investment in agency and digital channels.
Market Outlook and Final Thoughts
SBI Life’s numbers reflect a business scaling well operationally. Premium growth, embedded value gains, and stable solvency all support this view. The margin compression appears tied to product mix rather than any deeper weakness. For long-term investors, current price levels may offer a reasonable entry point, with brokerage targets pointing to healthy upside. As margin normalization plays out through the year, SBI Life’s scale and distribution strength should keep supporting its standing among India’s leading private insurers.